465 research outputs found

    A 64-channel, 1.1-pA-accurate on-chip potentiostat for parallel electrochemical monitoring

    Get PDF
    Electrochemical monitoring is crucial for both industrial applications, such as microbial electrolysis and corrosion monitoring as well as consumer applications such as personal health monitoring. Yet, state-of-the-art integrated potentiostat monitoring devices have few parallel channels with limited flexibility due to their channel architecture. This work presents a novel, widely scalable channel architecture using a switch capacitor based Howland current pump and a digital potential controller. An integrated, 64-channel CMOS potentiostat array has been fabricated. Each individual channel has a dynamic current range of 120dB with 1.1pA precision with up to 100kHz bandwidth. The on-chip working electrodes are post-processed with gold to ensure (bio)electrochemical compatibility

    An Integrated Platform for Differential Electrochemical and ISFET Sensing

    Get PDF
    A fully-integrated differential biosensing platform on CMOS is presented for miniaturized enzyme-based electrochemical sensing. It enables sensor background current elimination and consists of a differential sensor array and a differential readout IC (DiRIC). The sensor array includes a four-electrode sensor for amperometric electrochemical sensing, as well as a differential ISFET-based pH sensor to calibrate the biosensors. The ISFET is biased in weak inversion and co-designed with DiRIC to enable pH measurements from 1 to 14 with resolution of 0.1 pH. DiRIC enables differential current measurement in the range of ¿¿100 ¿¿A with more than 120dB dynamic range

    1.2V Energy-Efficient Wireless CMOS Potentiostat for Amperometric Measurements

    Get PDF
    Wireless biosensors are playing a pivotal role in health monitoring, disease detection and management. The development of wireless biosensor nodes and networks strongly relies on the design of novel low-power, low-cost and flexible CMOS sensor readouts. This paper presents a CMOS potentiostat that integrates a control amplifier, a dual-slope ADC and a wireless unit on the same chip. It implements a novel time-based readout scheme, whereby the counter of the dual-slope ADC is moved to the receiver and the sensor current is encoded in the timing between two wireless pulses transmitted via pulse-harmonic modulation across an inductive link. Measured results show that the potentiostat chip can resolve a minimum input current of 10pA at a sampling frequency of 125 Hz and a power consumption of 12 μW

    Digital CMOS ISFET architectures and algorithmic methods for point-of-care diagnostics

    Get PDF
    Over the past decade, the surge of infectious diseases outbreaks across the globe is redefining how healthcare is provided and delivered to patients, with a clear trend towards distributed diagnosis at the Point-of-Care (PoC). In this context, Ion-Sensitive Field Effect Transistors (ISFETs) fabricated on standard CMOS technology have emerged as a promising solution to achieve a precise, deliverable and inexpensive platform that could be deployed worldwide to provide a rapid diagnosis of infectious diseases. This thesis presents advancements for the future of ISFET-based PoC diagnostic platforms, proposing and implementing a set of hardware and software methodologies to overcome its main challenges and enhance its sensing capabilities. The first part of this thesis focuses on novel hardware architectures that enable direct integration with computational capabilities while providing pixel programmability and adaptability required to overcome pressing challenges on ISFET-based PoC platforms. This section explores oscillator-based ISFET architectures, a set of sensing front-ends that encodes the chemical information on the duty cycle of a PWM signal. Two initial architectures are proposed and fabricated in AMS 0.35um, confirming multiple degrees of programmability and potential for multi-sensing. One of these architectures is optimised to create a dual-sensing pixel capable of sensing both temperature and chemical information on the same spatial point while modulating this information simultaneously on a single waveform. This dual-sensing capability, verified in silico using TSMC 0.18um process, is vital for DNA-based diagnosis where protocols such as LAMP or PCR require precise thermal control. The COVID-19 pandemic highlighted the need for a deliverable diagnosis that perform nucleic acid amplification tests at the PoC, requiring minimal footprint by integrating sensing and computational capabilities. In response to this challenge, a paradigm shift is proposed, advocating for integrating all elements of the portable diagnostic platform under a single piece of silicon, realising a ``Diagnosis-on-a-Chip". This approach is enabled by a novel Digital ISFET Pixel that integrates both ADC and memory with sensing elements on each pixel, enhancing its parallelism. Furthermore, this architecture removes the need for external instrumentation or memories and facilitates its integration with computational capabilities on-chip, such as the proposed ARM Cortex M3 system. These computational capabilities need to be complemented with software methods that enable sensing enhancement and new applications using ISFET arrays. The second part of this thesis is devoted to these methods. Leveraging the programmability capabilities available on oscillator-based architectures, various digital signal processing algorithms are implemented to overcome the most urgent ISFET non-idealities, such as trapped charge, drift and chemical noise. These methods enable fast trapped charge cancellation and enhanced dynamic range through real-time drift compensation, achieving over 36 hours of continuous monitoring without pixel saturation. Furthermore, the recent development of data-driven models and software methods open a wide range of opportunities for ISFET sensing and beyond. In the last section of this thesis, two examples of these opportunities are explored: the optimisation of image compression algorithms on chemical images generated by an ultra-high frame-rate ISFET array; and a proposed paradigm shift on surface Electromyography (sEMG) signals, moving from data-harvesting to information-focused sensing. These examples represent an initial step forward on a journey towards a new generation of miniaturised, precise and efficient sensors for PoC diagnostics.Open Acces

    Crexens™: an expandable general-purpose electrochemical analyzer

    Get PDF
    2019 Fall.Includes bibliographical references.Electrochemical analysis has gained a great deal of attention of late due to its low-cost, easy-to-perform, and easy-to-miniaturize, especially in personal health care where accuracy and mobility are key factors to bring diagnostics to patients. According to data from Centers for Medicare & Medicaid Services (CMS) in the US, the share of health expenditure in the US has been kept growing in the past 3 decades and reached 17.9% of its overall Gross Domestic Product till 2016, which is equivalent to 10,348foreverypersonintheUSperyear.Ontheotherhand,healthcareresourcesareoftenlimitednotonlyinruralareabutalsoappearedinwelldevelopedcountries.TheurgentneedandthelackofhealthresourcebringstofronttheresearchinterestofPointofCare(PoC)diagnosisdevices.Electrochemicalmethodshavebeenlargelyadoptedbychemistandbiologistfortheirresearchpurposes.However,severalissuesexistwithincurrentcommercialbenchtopinstrumentsforelectrochemicalmeasurement.Firstofall,thecurrentcommercialinstrumentsareusuallybulkyanddonothavehandheldfeatureforpointofcareapplicationsandthecostareeasilynear10,348 for every person in the US per year. On the other hand, health care resources are often limited not only in rural area but also appeared in well-developed countries. The urgent need and the lack of health resource brings to front the research interest of Point-of-Care (PoC) diagnosis devices. Electrochemical methods have been largely adopted by chemist and biologist for their research purposes. However, several issues exist within current commercial benchtop instruments for electrochemical measurement. First of all, the current commercial instruments are usually bulky and do not have handheld feature for point-of-care applications and the cost are easily near 5,000 each or above. Secondly, most of the instruments do not have good integration level that can perform different types of electrochemical measurements for different applications. The last but not the least, the existing generic benchtops instruments for electrochemical measurements have complex operational procedures that require users to have a sufficient biochemistry and electrochemistry background to operate them correctly. The proposed Crexens™ analyzer platform is aimed to present an affordable electrochemical analyzerwhile achieving comparable performance to the existing commercial instruments, thus, making general electrochemical measurement applications accessible to general public. In this dissertation, the overall Crexens™ electrochemical analyzer architecture and its evolution are presented. The foundation of the Crexens™ architecture was derived from two separate but related research in electrochemical sensing. One of them is a microelectrode sensor array using CMOS for neurotransmitter sensing; the other one is a DNA affinity-based capacitive sensor for infectious disease, such as ZIKA. The CMOS microelectrode sensor array achieved a 320uM sensitivity for norepinephrine, whereas the capacitive sensor achieved a dynamic range of detection from 1 /uL to 105 /uL target molecules (20 to 2 million targets), which makes it be within the detection range in a typical clinical application environment. This dissertation also covers the design details of the CMOS microelectrode array sensor and the capacitive sensor design as a prelude to the development of the Crexens™ analyzer architecture. Finally, an expandable integrated electrochemical analyzer architecture (Crexens™) has been designed for mobile point-of-care (POC) applications. Electrochemical methods have been explored in detecting various bio-molecules such as glucose, lactate, protein, DNA, neurotransmitter, steroid hormone, which resulted in good sensitivity and selectivity. The proposed system is capable of running electrochemical experiments including cyclic voltammetry (CV), electrochemical impedance spectroscopy (EIS), electrochemical capacitive spectroscopy (ECS), amperometry, potentiometry, and other derived electrochemical based tests. This system consist of a front-end interface to sensor electrodes, a back-end user interface on smart phone and PC, a base unit as master module, a low-noise add-on module, a high-speed add-on module, and a multi-channel add-on module. The architecture allows LEGO™-like capability to stack add-on modules on to the base-unit for performance enhancements in noise, speed or parallelism. The analyzer is capable of performing up to 1900 V/s CV with 10 mV step, up to 12 kHz EIS scan range and a limit of detection at 637 pA for amperometric applications with the base module. With high performance module, the EIS scan range can be extended upto 5 MHz. The limit of detection can be further improved to be at 333 fA using the low-noise module. The form factor of the electrochemical analyzer is designed for its mobile/point-of-care applications, integrating its entire functionality on to a 70 cm² area of surface space. A glutamine enzymatic sensor was used to valid the capability of the proposed electrochemical analyzer and turned out to give good linearity and reached a limit of detection at 50 uM

    Bioelectronics for Amperometric Biosensors

    Get PDF
    The Discrete-to-Integrated Electronics group (D2In), at the University of Barcelona, in partnership with the Bioelectronics and Nanobioengineering Group (SICBIO), is researching Smart Self-Powered Bio-Electronic Systems. Our interest is focused on the development of custom built electronic solutions for bio-electronics applications, from discrete devices to Application-specific integrated circuit (ASIC) solutions. The integration of medical and electronic technologies allows the development of biomedical devices able to diagnose and/or treat pathologies by detecting and/or monitoring pathogens, multiple ions, PH changes, and so on. Currently this integration enables advances in various areas such as microelectronics, microfluidics, microsensors and bio-compatible materials which open the door to developing human body Lab-on-a-Chip implantable devices, Pointof- Care in vitro devices, etc. In this chapter the main attention is focused on the design of instrumentation related to amperometrics biosensor: biopotentiostat amplifiers and lock-in amplifiers. A potentiostat is a useful tool in many fields of investigation and industry performing electrochemical trials [1], so the quantity and variety of them is very extensive. Since they can be used in studies and targets as different as the study of chemical metal conversions [2] or carcinogenic cells detection, neuronal activity detection or Deoxyribonucleic acid (DNA) recognition, their characteristics are very varied..

    Fully Integrated Biochip Platforms for Advanced Healthcare

    Get PDF
    Recent advances in microelectronics and biosensors are enabling developments of innovative biochips for advanced healthcare by providing fully integrated platforms for continuous monitoring of a large set of human disease biomarkers. Continuous monitoring of several human metabolites can be addressed by using fully integrated and minimally invasive devices located in the sub-cutis, typically in the peritoneal region. This extends the techniques of continuous monitoring of glucose currently being pursued with diabetic patients. However, several issues have to be considered in order to succeed in developing fully integrated and minimally invasive implantable devices. These innovative devices require a high-degree of integration, minimal invasive surgery, long-term biocompatibility, security and privacy in data transmission, high reliability, high reproducibility, high specificity, low detection limit and high sensitivity. Recent advances in the field have already proposed possible solutions for several of these issues. The aim of the present paper is to present a broad spectrum of recent results and to propose future directions of development in order to obtain fully implantable systems for the continuous monitoring of the human metabolism in advanced healthcare applications

    Low power cmos potentiometric circuit design for label-free DNA detection

    Get PDF
    DNA detector is one of the main way to use in order to detect diseases, preventing crime and so on. The DNA detecting process is limited due to the bulky and expensive existing DNA detector machine. As the demand of the small, portable and inexpensive biosensor for point-of-care testing aid and medical diagnostic, the research and development of biosensor are increasing exponentially every year. The aim of this work is to develop an on-chip Complementary Metal Oxide Semiconductor (CMOS) biosensor circuit based on the charge-modulated field effect transistor (CMFET) for a label-free deoxyribonucleic acid (DNA) detection. This project focusing on low voltage and low power design potentiometric DNA detection circuit. Overall of detection circuit consists of two main circuits which are self-cascode source drain follower and two-stage differential amplifier. The proposed detection circuit is designed and simulates using 0.13 µm Silterra CMOS fabrication with 1.2 V supply. The power consumption of the improved source-drain follower circuit is 1.36 µW and with gain of 0.998 dB. The two-stage differential amplifier achives a voltage gain of 56.02 dB and high common mode rejection ration (CMRR) of 90 dB
    corecore